Genopathy
Gene-Disorder Association · Article
Gene
LOC108491825
Enhancer-Blocking Element 11-1-2 Overlapping APOA5
Disorder
Hyperlipoproteinemia, Type V
First reported 1964
Key publication · disorder [ANALYTIC STUDY OF LIPOPROTEINS BY PREPARATORY ULTRACENTRIFUGATION IN 21 CASES OF MAJOR HYPERLIPIDEMIA].Revue francaise d'etudes cliniques et biologiques · 1964
Association Review

In brief

The association between LOC108491825 (Enhancer-Blocking Element 11-1-2 Overlapping APOA5) and Hyperlipoproteinemia, Type V is supported by expert-curated evidence, drawing on a single expert-curated source, which records likely-pathogenic variants.

Sources 1
Clinical variants 3
Symptoms 9
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
LOC108491825

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Hyperlipoproteinemia, Type V

The disorder

11 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

5 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
ClinVar and variant evidence

Genetic basis

3 clinical variants

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
07
Provenance

References & sources

5 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access